Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.04 HKD | +0.56% | +0.22% | +29.60% |
04-18 | Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31 | MT |
04-01 | SciClone Pharmaceuticals Logs 31% Increase in 2023 Profit | MT |
Business Summary
Number of employees: 860
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 3,198 | 100.0 % | 3,487 | 100.0 % | +9.05% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
96.7
%
| 3,103 | 97.0 % | 3,373 | 96.7 % | +8.71% |
Others
3.3
%
| 94 | 3.0 % | 114 | 3.3 % | +20.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hong Zhao
CEO | Chief Executive Officer | 60 | 31/05/20 |
Rong Rong Pan
DFI | Director of Finance/CFO | 46 | - |
Mao Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 12/06/22 |
Lian Zong Wu
PRN | Corporate Officer/Principal | 50 | - |
Min Jia
PRN | Corporate Officer/Principal | 53 | - |
Yan Song Chang
PRN | Corporate Officer/Principal | 56 | - |
Ming Xiang Wu
PRN | Corporate Officer/Principal | 58 | - |
Chih Wen Shao
PRN | Corporate Officer/Principal | 61 | - |
Lingyu Zhu
PRN | Corporate Officer/Principal | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Vasella
BRD | Director/Board Member | 70 | 31/05/20 |
Hong Zhao
CEO | Chief Executive Officer | 60 | 31/05/20 |
Zhen Fu Li
CHM | Chairman | 59 | 31/05/20 |
Guo En Liu
BRD | Director/Board Member | 67 | - |
Wendy Hayes
BRD | Director/Board Member | 54 | 28/02/21 |
Yushao Gu
BRD | Director/Board Member | 55 | - |
Rong Rong Pan
DFI | Director of Finance/CFO | 46 | - |
Ping Chen
BRD | Director/Board Member | 66 | - |
Hai Xia Wang
BRD | Director/Board Member | 50 | 15/06/21 |
Director/Board Member | 42 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 627,646,692 | 338,971,511 ( 54.01 %) | 0 | 54.01 % |
Company contact information
SciClone Pharmaceuticals (Holdings) Ltd.
22/F, Central Plaza 381 Middle Huaihai Road
200020, Shanghai
+
http://www.sciclone.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.60% | 1.4B | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-16.66% | 31.47B | |
+53.68% | 25.24B | |
-14.38% | 15.82B | |
-9.12% | 11.96B | |
-16.10% | 11.89B | |
-42.56% | 11.61B | |
+4.94% | 8.84B |
- Stock Market
- Equities
- 6600 Stock
- Company SciClone Pharmaceuticals (Holdings) Limited